Cargando…
Treating systemic lupus erythematosus in the 21st century: new drugs and new perspectives on old drugs
Besides treating acute flares, the management of SLE should aim at preventing organ damage accrual and drug-associated harms, improving health-related quality of life and prolonging survival. At present, therapy is based on combinations of antimalarials (mainly HCQ), considered the backbone of SLE t...
Autores principales: | Ruiz-Irastorza, Guillermo, Bertsias, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719039/ https://www.ncbi.nlm.nih.gov/pubmed/33280011 http://dx.doi.org/10.1093/rheumatology/keaa403 |
Ejemplares similares
-
Classifying and diagnosing systemic lupus erythematosus in the 21st century
por: Aringer, Martin, et al.
Publicado: (2020) -
Lupus nephritis: clinical presentations and outcomes in the 21st century
por: Gasparotto, Michela, et al.
Publicado: (2020) -
The management of neuropsychiatric lupus in the 21st century: still so many unmet needs?
por: Govoni, Marcello, et al.
Publicado: (2020) -
New developments in systemic lupus erythematosus
por: Tsang-A-Sjoe, Michel W. P., et al.
Publicado: (2021) -
Introduction to comments on 'Outsourcing: how to reform WHO for the 21st century'
por: Abimbola, Seye
Publicado: (2017)